Printer Friendly

AVVAA COMPLETES DISTRIBUTOR PACT WITH GALAMAN.

avVaa World Health Care Products, Inc. (BULLETIN BOARD: AVVW), Lumby, BC, Canada, a biotechnology company offering global customers therapeutic skin and health care products, has signed a distributor agreement with Galaman Ltd., based in Greater Toronto area, Canada for the distribution of avVaa Care Equine and Pet product lines and avVaa Vet Equine and Pet product lines.

Lorie Campbell-Farley, EVP Sales and Marketing for avVaa said, "While full commercialization of other lines at avVaa is on-going, we are committed to researching and developing our secondary lines of equine and pet products to meet the needs of one of the fastest growing segments of the retail market, now a $31 billion industry."

Campbell-Farley continued, "A nationally recognized distributor like Galaman has the ability to strategically place our equine, vet and pet product lines on a national level. We look forward to a mutually beneficial relationship as we move forward in this important sector."

avVaa Care and avVaa Vet products were developed utilizing the healing powers of avVaa's Neuroskin formulas providing the Equine and Pet Industry with all natural patented nano-fine mineral solution products that quickly treat many skin disorders common to animals.

About Galaman Ltd.

Galaman Ltd. is a Canadian company specializing in innovative equine and small animal products for distribution to 350 plus equine Veterinary Practices and 3000 plus small animal Veterinary Practices throughout Canada. Galaman Ltd was developed to provide the equine athlete and small animals with only the highest quality products to enhance, promote and maintain their physical condition.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its O-T-C Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.

For more information, visit: http://www.avvaa.com or http://www.otcfn.com/avvw or call 604/688-2349.
COPYRIGHT 2006 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Date:Feb 1, 2006
Words:360
Previous Article:AASTROM BIOSCIENCES REPORTS POSITIVE HUMAN JAW BONE RESULTS.
Next Article:NORWOOD IMMUNOLOGY TAKES OPTION FOR VACCINE TECHNOLOGY.
Topics:


Related Articles
RUSSIA - May 28 - Open Skies Treaty Ratified.
PROGRAM AIDING CHILDREN EXPANDS TO A.V.
STATE FLOWER GROWERS SEEK TO PRUNE ANDEAN IMPORTS.
Building the Post-Kyoto future: the new U.S.-Asian pact on global warming has more to do with transferring technology to China than with saving the...
Trading up.
Ancient Pact.
Estimates of pregnancies averted through California's family planning waiver program in 2002.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters